Device Trial Radar · NCT04419714
TatchSleep as a Tool to Aid in Sleep Apnea Analysis
Last checked: Nov 19, 2026Latest source record: Aug 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
53
Actual
Start
Jun 10, 2021
Primary completion
Nov 4, 2021
Study completion Nov 4, 2021
Sponsor
- Lead sponsor
- Wesper IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 5, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 120 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a single center, single-arm, quantitative study evaluating the efficacy of the TatchSleep wireless sensor patches as a tool to aid in sleep apnea analysis as compared to an overnight PSG evaluation.
Conditions
- Sleep Apnea
- Sleep Disorder
Interventions
TatchSleepDevice
Wearable measurement device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Correlation Between Polysomnography (PSG) and Tatch Apnea/Hypopnea Index (AHI)Time frame: 12 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Montefiore Medical Center
The Bronx, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.